1. PRAISE: providing a roadmap for automated infection surveillance in Europe
- Author
-
van Mourik, Maaike S M, van Rooden, Stephanie M, Abbas, Mohamed, Aspevall, Olov, Astagneau, Pascal, Bonten, Marc J M, Carrara, Elena, Gomila-Grange, Aina, de Greeff, Sabine C, Gubbels, Sophie, Harrison, Wendy, Humphreys, Hilary, Johansson, Anders, Koek, Mayke B G, Kristensen, Brian, Lepape, Alain, Lucet, Jean-Christophe, Mookerjee, Siddharth, Naucler, Pontus, Palacios-Baena, Zaira R, Presterl, Elisabeth, Pujol, Miquel, Reilly, Jacqui, Roberts, Christopher, Tacconelli, Evelina, Teixeira, Daniel, Tängdén, Thomas, Valik, John Karlsson, Behnke, Michael, Gastmeier, Petra, PRAISE network, ZonMw, Innovative Medicines Initiative, European Commission, European Federation of Pharmaceutical Industries and Associations, VINNOVA (Sweden), Pfizer, Astellas Pharma, University Medical Center [Utrecht], National Institute for Public Health and the Environment [Bilthoven] (RIVM), Geneva University Hospital (HUG), Public Health Agency of Sweden, Centre d'appui pour la prévention des infections associées aux soins [Île-de-France] (Cpias Île-de-France), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Department of Diagnostics and Public Health [Verona] (UNIVR | DDSP), University of Verona (UNIVR), Institut d'Investigació Biomèdica de Bellvitge [Barcelone] (IDIBELL), Statens Serum Institut [Copenhagen], Public Health Wales, Royal College of Surgeons in Ireland (RCSI), Umeå University, Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hammersmith Hospital NHS Imperial College Healthcare, Karolinska Institutet [Stockholm], Karolinska University Hospital [Stockholm], Biomedicine Institute of Sevilla [Seville, Spain], Medizinische Universität Wien = Medical University of Vienna, Glasgow Caledonian University (GCU), German Center for Infectious Research - partner site Tübingen [Tübingen, Allemagne] (DZIF), Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Uppsala Universitet [Uppsala], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Freie Universität Berlin, and Humboldt-Universität zu Berlin
- Subjects
Infektionsmedicin ,Medical care ,MESH: Infection Control ,Automation ,0302 clinical medicine ,MESH: Automation ,Bloodstream infection ,Infection control ,030212 general & internal medicine ,Praise ,media_common ,0303 health sciences ,Cross Infection ,Data ,Surveillance ,virus diseases ,General Medicine ,Quality ,Infeccions ,3. Good health ,Europe ,Infectious Diseases ,Vigilància electrònica ,Epidemiological Monitoring ,Electronic surveillance ,Medical emergency ,Surgical site infection ,Microbiology (medical) ,Healthcare associated infections ,Automated ,Infectious Medicine ,animal structures ,media_common.quotation_subject ,Electronic health record ,Infections ,03 medical and health sciences ,medicine ,Humans ,Healthcare-associated infection ,Infection surveillance ,Infection Control ,MESH: Humans ,030306 microbiology ,business.industry ,MESH: Cross Infection ,medicine.disease ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,MESH: Epidemiological Monitoring ,MESH: Europe ,business - Abstract
[Introduction] Healthcare-associated infections (HAI) are among the most common adverse events of medical care. Surveillance of HAI is a key component of successful infection prevention programmes. Conventional surveillance – manual chart review – is resource intensive and limited by concerns regarding interrater reliability. This has led to the development and use of automated surveillance (AS). Many AS systems are the product of in-house development efforts and heterogeneous in their design and methods. With this roadmap, the PRAISE network aims to provide guidance on how to move AS from the research setting to large-scale implementation, and how to ensure the delivery of surveillance data that are uniform and useful for improvement of quality of care., [Methods] The PRAISE network brings together 30 experts from ten European countries. This roadmap is based on the outcome of two workshops, teleconference meetings and review by an independent panel of international experts., [Results] This roadmap focuses on the surveillance of HAI within networks of healthcare facilities for the purpose of comparison, prevention and quality improvement initiatives. The roadmap does the following: discusses the selection of surveillance targets, different organizational and methodologic approaches and their advantages, disadvantages and risks; defines key performance requirements of AS systems and suggestions for their design; provides guidance on successful implementation and maintenance; and discusses areas of future research and training requirements for the infection prevention and related disciplines. The roadmap is supported by accompanying documents regarding the governance and information technology aspects of implementing AS., [Conclusions] Large-scale implementation of AS requires guidance and coordination within and across surveillance networks. Transitions to large-scale AS entail redevelopment of surveillance methods and their interpretation, intensive dialogue with stakeholders and the investment of considerable resources. This roadmap can be used to guide future steps towards implementation, including designing solutions for AS and practical guidance checklists., This network has been supported under the 7th transnational call within the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), Network Call on Surveillance (2018) and was thereby funded by ZonMw (grant 549007001). This project also received support from the COMBACTE MAGNET EPI-Net project funded by the Innovative Medicines Initiative Joint Undertaking under grant agreement 115523 | 115620 | 115737 | 777362, resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. J.K.V. was supported by grants from Region Stockholm and Vinnova. H.H. reports grants from Pfizer and Astellas as well as personal fees from Pfizer outside the submitted work.
- Published
- 2021
- Full Text
- View/download PDF